# Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

> **NCT05374252** · PHASE3 · UNKNOWN · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 102 (estimated)

## Conditions studied

- Anal Canal Cancer Stage III
- Anal Squamous Cell Carcinoma
- Anal Canal Cancer
- Anal Cancer

## Interventions

- **DRUG:** PD-1 inhibitor
- **RADIATION:** concurrent chemoradiotherapy

## Key facts

- **NCT ID:** NCT05374252
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-07
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05374252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05374252, "Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05374252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*